Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
NCL and Progressive Myoclonic Epilepsy Panel Blueprint Genetics Finland | 2 | 31 |
|
Neurogenetic Disorders - panels MGZ Medical Genetics Center Germany | 14 | 597 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Leukodystrophy / Leukencephalopathy and differential diagnoses Panel CeGaT GmbH Germany | 69 | 175 |
|
Nuclear encoded Mitochondriopathies Panel CeGaT GmbH Germany | 37 | 284 |
|
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel CeGaT GmbH Germany | 147 | 143 |
|
MGZ Medical Genetics Center Germany | 17 | 212 |
|
MGZ Medical Genetics Center Germany | 6 | 131 |
|
MGZ Medical Genetics Center Germany | 6 | 168 |
|
Epilepsy and Mitochondrial Encephalopathy MGZ Medical Genetics Center Germany | 17 | 186 |
|
Mitochondrial Diseases (mtDNA and 217 nuclear genes) Asper Biogene Asper Biogene LLC Estonia | 89 | 210 |
|
Fulgent Genetics United States | 1 | 1 |
|
Combined Respiratory Chain Defects MGZ Medical Genetics Center Germany | 3 | 32 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.